10x Genomics and BioTuring Partner to Streamline Single Cell and Spatial Data Analysis

Reuters
01/26
<a href="https://laohu8.com/S/TXG">10x Genomics</a> and BioTuring Partner to Streamline Single Cell and Spatial Data Analysis

10x Genomics Inc. has announced a strategic collaboration with BioTuring to streamline and accelerate single cell and spatial data analysis. The partnership integrates 10x Genomics’ Chromium, Xenium, and Visium platforms with BioTuring’s advanced analytical ecosystem, delivering a seamless end-to-end workflow for researchers working with complex single cell and spatial multiomics data. The collaboration aims to reduce fragmented analysis workflows and enhance the speed and depth of biological interpretation by leveraging BioTuring’s GPU-accelerated architecture and coordinated educational resources. Additionally, 10x Genomics customers new to BioTuring will receive a 30-day free access period to BioTuring’s analysis platform, with preferred pricing available thereafter. By mid-2026, the partnership is expected to enable direct data transfer from 10x Cloud Analysis into BioTuring’s platforms, further simplifying the analysis process.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief on January 26, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10